https://www.fiercepharma.com/pharma/asco-merck-details-keytruda-s-second-stomach-cancer-slip
https://www.evaluate.com/vantage/articles/events/conferences/asco-2019-top-marks-effort-merck-co-gastric-cancer
Merck's second stomach cancer slip could turn out to be quite auspicious for us, as they now have to go back to the drawing board and design a new trial. Interestingly, Dr. Josep Tabernero was the trial's lead investigator and has also been a consultant to Merck in the past. I think it's safe to assume that Dr Josep Tabernero has the eyes and ears of Merck's people.
From the below photo (November 2018), we know that we already have made contact with Merck's people.
Interesting times ahead.
https://www.facebook.com/Imugene/photos/a.572970402723551/2148644111822831/?type=3&theater![]()
- Forums
- ASX - By Stock
- IMU
- ASCO Conference
ASCO Conference, page-25
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.2¢ | 5.3¢ | 5.1¢ | $525.2K | 10.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 92800 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 1045565 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70000 | 0.052 |
31 | 3304831 | 0.051 |
67 | 5510210 | 0.050 |
18 | 2192645 | 0.049 |
21 | 798435 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 1045565 | 9 |
0.054 | 3292324 | 10 |
0.055 | 791261 | 7 |
0.056 | 2579035 | 12 |
0.057 | 509484 | 7 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online